Satoshi Higuchi1, Hideki Ota1, Kazumasa Seiji1, Yuta Tezuka2, Ryo Morimoto2, Tatsuya Nishii3, Tetsuya Fukuda3, and Kei Takase1
1Diagnostic Radiology, Tohoku university hospital, Sendai, Japan, 2Endocrinology, Tohoku university hospital, Sendai, Japan, 3Radiology, National cerebral and cardiovascular center, Suita, Japan
Synopsis
The purpose of this study is to compare cardiac morphology,
function and tissue characteristics between patients with two subtypes of
primary aldosteronism (PA), aldosterone-producing adenoma (APA) and bilateral
hyperaldosteronism (BHA). One-hundred-and-forty-three consecutive PA patients
underwent 3T MR examinations including cine, late gadolinium enhancement and
pre- and post-contrast T1 mapping. APA group demonstrated higher myocardial
native T1 and left-ventricular end-diastolic volume index than BHA after
controlling for patients’ demographic data. The results indicate that APA
group, with higher hormonal activity than BHA, may be suffered from LV volume
overload and myocardial fibrosis or edema as compared with BHA group.
Introduction
Primary Aldosteronism (PA) is
one of the most frequent forms of secondary hypertension. The excess
aldosterone has been associated with various cardiovascular damages (1); it has
increased risks of cardiovascular events relative to patients with essential
hypertension, resulting in increased cardiovascular mortality (2). Two most
common causes of PA are unilateral aldosterone-producing adenomas (APAs) and
bilateral hyperaldosteronism (BHA). APAs often secrete higher amounts of
adrenocortical hormone compared to adrenals of BAH patients. In
echocardiographic assessment, left ventricular (LV) end-diastolic and
end-systolic diameters, and LV mass were greater in APA group than BHA group
(3). However, there has been little reports comparing cardiac characteristics
among subtypes of PA. The purpose of this study is to compare cardiac
morphology, function and tissue characteristics between patients with APAs and
BHA using a 3T MR scanner.Methods
We included 143 consecutive
patients with PA and no history of heart disease or severe renal dysfunction
(mean age, 52±12 years, male, 75). All patients were diagnosed by
endocrinologists from September 2015 to May 2018 according to a Japanese
guideline. (4) All patients underwent cardiac MR examination and adrenal venous
sampling to determine the laterality of the PA lesion. Scan protocols included
cine, late gadolinium enhancement (LGE) and pre- and post-contrast T1 mapping
by modified Look-Locker inversion recovery. We evaluated the presence of LGE,
native T1 values and extracellular volume (ECV) and the following LV volumetric
parameters: end-diastolic and end-systolic septum wall thickness, ejection
fraction, end-diastolic, end-systolic and stroke volume index (EDVI, ESVI and
SI), cardiac index (CI) and LV mass index. Regions of interests for evaluation
of native T1 and ECV were placed on the mid-wall of the basal septum. Patients'
demographic characteristics were collected; including sex, age, body mass
index, family history of essential hypertension, medical history of diabetes
mellitus, smoking history, the number of antihypertensive drugs, home systolic
blood pressure and disease duration which is the interval from appearance of
subjective symptoms or notice of hypertension to the diagnosis. We also
collected the level of plasma aldosterone concentration (PAC). Fisher’s exact
test was used for dichotomous data, and variables between the two groups with
APAs and BHA were compared using Student t-tests or Mann-Whitney’s U tests.
Associations among MR parameters, patients' demographic data and subtypes of PA
were examined using multivariate logistic regression models. Spearman’s rank
correlation coefficient was used to evaluate correlations between two
parameters. P < 0.05 was considered statistically
significant. Results
Subtypes of PA were diagnosed as APA in 70 (male, 45)
and BHA in 73 (male, 30) patients by adrenal venous sampling. In the
demographic data, the male proportion (APA vs. BHA = 64% vs. 41%, p<0.01),
disease duration (8.5[4-15] vs. 5[2-10.5] years, p=0.03) and the number of
antihypertensive drugs (2[1-2] vs. 1[1-2], p<0.01) were significantly larger
in APA group than BHA group. After controlling for these parameters as
confounders, APA group showed significantly higher native T1 (adjusted odds
ratio [aOR] =1.01 [95% CI: 1.000-1.019], p=0.038), EDVI (aOR=1.06 [95% CI:
1.030-1.096], p<0.01), ESVI (aOR =1.06 [95% CI: 1.017-1.113], p<0.01), SI
(aOR=1.07, [95% CI: 1.020-1.121], p<0.01), CI (aOR=1.001 [95% CI:
1.000-1.001], p<0.01) than BHA group. APA group showed significantly higher
PAC levels than the other (log PAC; 1.7 ± 0.3 vs. 1.3 ± 0.1, p<0.01). Log
PAC have positive correlations with EDVI (R=0.28 p<0.01), ESVI (R=0.26
p<0.01) and SI (R=0.18 p=0.03).Discussion
Aldosterone is the main mineralocorticoid hormone
which promotes water retention. Our results indicated the influence of acting
aldosterone was severer on LV volumetric parameters in APA group with higher
aldosterone activity than BHA group, suggesting APA patients are exposed to
increased risk of LV volume overload. Moreover, we revealed these volumetric
parameters have positive correlations with PAC. Past MR
study showed patients with PA demonstrated a significant increase in the
frequency of LV hypertrophy and LGE than patients with essential hypertension
(5,6). In this study, LV mass, ECV and presence of LGE did not show the
significant difference between the two groups; however, elevated native T1
values in APA group may indicate they have mild myocardial fibrosis or edema.
Follow-up MR studies are needed to reveal whether resection of the functioning
adrenal tumors improves the MR findings in APA group. Moreover, clinical
follow-up is also needed to determine the long-term clinical significance of
these results.Conclusion
After controlling for patients’ demographic data, APA with higher
hormonal activity than BHA demonstrated higher LV volume parameters and
myocardial native T1. Among PA patients, APA group may have an increase in the
frequency of LV volume overload and mild myocardial fibrosis or edema than BHA
group.Acknowledgements
No acknowledgement found.References
- Rossi G-P, Sechi LA, Giacchetti G,
Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular,
renal and metabolic implications. Trends Endocrinol Metab. 2008 Apr;19(3):88–90.
- Monticone
S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al.
Cardiovascular events and target organ damage in primary aldosteronism compared
with essential hypertension: a systematic review and meta-analysis. Lancet
Diabetes Endocrinol. 2018 Jan 1;6(1):41–50.
- Hidaka
T, Shiwa T, Fujii Y, Nishioka K, Utsunomiya H, Ishibashi K, et al. Impact of
aldosterone-producing adenoma on cardiac structures in echocardiography. J
Echocardiogr. 2013 Dec;11(4):123–9.
- Nishikawa
T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for
the diagnosis and treatment of primary aldosteronism -The Japan Endocrine
Society 2009-. Endocr J. 2011;58(9):711–21.
- Freel
EM, Mark PB, Weir RAP, McQuarrie EP, Allan K, Dargie HJ, et al. Demonstration
of Blood Pressure-Independent Noninfarct Myocardial Fibrosis in Primary
Aldosteronism: A Cardiac Magnetic Resonance Imaging Study. Circ Cardiovasc
Imaging. 2012 Nov 1;5(6):740–7.
- Gaddam
K, Corros C, Pimenta E, Ahmed M, Denney T, Aban I, et al. Rapid Reversal of
Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With
Resistant Hypertension and Hyperaldosteronism. Hypertension. 2010 May 1